ExodusPoint Capital Management, LP - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 209 filers reported holding BRIDGEBIO PHARMA INC in Q2 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.5%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q1 2023$209
-100.0%
12,624
-92.3%
0.00%
-90.5%
Q3 2022$1,620,000
-24.4%
162,981
-31.0%
0.02%
-19.2%
Q2 2022$2,144,000
+129.1%
236,112
+155.9%
0.03%
+116.7%
Q1 2022$936,000
-24.3%
92,258
+249.6%
0.01%
-29.4%
Q3 2021$1,237,000
+84.4%
26,393
+142.4%
0.02%
+70.0%
Q1 2021$671,00010,8890.01%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$373,797,00067.28%
Darwin Global Management, Ltd. 2,090,149$128,753,00025.21%
Affinity Asset Advisors, LLC 577,500$35,574,00012.08%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$1,913,356,0009.64%
Perceptive Advisors 7,756,928$477,827,0006.04%
Opaleye Management Inc. 583,767$35,960,0005.28%
MIZUHO MARKETS AMERICAS LLC 171,923$10,590,0004.93%
VIKING GLOBAL INVESTORS LP 26,620,991$1,639,853,0004.88%
Fernwood Investment Management, LLC 151,085$9,307,0003.42%
HHLR ADVISORS, LTD. 5,362,014$330,300,0003.26%
View complete list of BRIDGEBIO PHARMA INC shareholders